Matrix metalloproteinases in pathophysiology and treatment of heart failure
- 1 March 2001
- journal article
- Published by Elsevier in The Lancet
- Vol. 357 (9257) , 654-655
- https://doi.org/10.1016/s0140-6736(00)04151-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Cardiac interstitium in health and disease: The fibrillar collagen networkPublished by Elsevier ,2010
- Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor α can be modulated by anti-tumor necrosis factor α therapyProceedings of the National Academy of Sciences, 2000
- Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodelingCardiovascular Research, 2000
- Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic targetCardiovascular Research, 2000
- Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human HeartCirculation, 1998
- Increased Matrix Metalloproteinase Activity and Selective Upregulation in LV Myocardium From Patients With End-Stage Dilated CardiomyopathyCirculation, 1998
- Time-Dependent Changes in Matrix Metalloproteinase Activity and Expression During the Progression of Congestive Heart FailureCirculation Research, 1998
- Matrix Metalloproteinases and Cardiovascular DiseaseCirculation Research, 1995
- Inadequate collagen tethers in dilated cardiopathyAmerican Heart Journal, 1988
- Über die Trophospongien der quergestreiften Muskelfasern, nebst Bemerkungen über den allgemeinen Bau dieser FasernArchiv für Mikroskopische Anatomie, 1907